[对IgA脏病的诊断和治疗-2023]
Judith Schimpf1, Andreas Kronbichler2, Martin Windpessl3,4
1Abteilung für Innere Medizin III (Nephrologie, Dialyse und Hypertensiologie), Akademisches Lehrkrankenhaus Feldkirch, Feldkirch, Österreich.
Wiener klinische Wochenschrift
|September 20, 2023
概括
免疫球蛋白A脏病 (IgAN) 是一种常见的脏疾病. 了解其免疫失调和优化支持性护理,包括血压控制和SGLT2抑制剂,是控制IgAN进展的关键.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 免疫球蛋白A腎病 (IgAN) 是最常見的膠質球炎形式,可能導致大量患者進行末期腎病.
- 确切的Igan的致病性并未完全理解,但涉及免疫失调,导致免疫复合物的形成和沉积在脏.
- 必须确定和管理Igan的二次原因,如炎症性肠病,感染,瘤和类风湿性疾病.
研究的目的:
- 阐明IgAN复杂的发病过程,重点关注免疫系统的失调和致病性IgA免疫复合物的形成.
- 突出IGAN的诊断标准,强调脏活检和组织学分类 (MEST-C评分) 的必要性,以预后.
- 审查目前和新兴的Igan治疗策略,包括支持性护理,免疫抑制和新药.
主要方法:
- 关于IgAN病变发生,诊断和治疗的当前文献的综述.
- 对Igan患者特征性临床和组织学发现的分析.
- 对辅助疗法,免疫抑制疗法和新型治疗剂的评估.
主要成果:
- 伊格安的发病与低银基化IgA和IgG自身抗体有关,形成免疫复合体,这些复合体沉积在淋巴细胞中,导致炎症.
- 诊断的标志包括性尿沉积物,蛋白尿,功能受损,高血压和血,确定的诊断需要活检.
- 优化的支持疗法 (血压控制,RAS抑制,SGLT2抑制剂) 是至关重要的;免疫抑制是有争议的,而肠道布德塞诺因和斯帕森坦显示出希望.
结论:
- 对IGAN的管理需要采用全面的方法,解决潜在的次要原因并优化支持性护理.
- 通过脏活检和组织学评分进行准确的诊断对于指导治疗和预测预后至关重要.
- 进一步研究新的治疗方法,如布德森尼德和斯帕森坦是有必要的,以改善IGAN患者的结果.
相关概念视频
01:28Chronic Kidney Disease III: Interprofessional Care
41
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
41
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
34
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
34
01:26Nephrotic Syndrome II : Assessment and Medical Management
8
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
8
01:24Nephrotic Syndrome III : Nursing Management
19
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
19
01:29Acute Kidney Injury III: Clinical Manifestations
29
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
29
01:20Acute Kidney Injury V: Interprofessional Care
25
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
25